Oxford researchers have launched a study investigating the impact of the COVID-19 pandemic on sleep and daily rhythms in adults. The UK arm of the International COVID-19 Sleep Study (ICOSS) is led by Professor Colin Espie from the Nuffield Department of Clinical Neurosciences at the University of Oxford and is funded by the NIHR Oxford … Read more
News for COVID-19
Oxford leads part of major COVID-19 drugs trial
As part of a new UK trial researchers at the University of Oxford will investigate whether administering the anti-inflammatory drug infliximab to patients with COVID-19 can prevent progression to respiratory failure or death. The multi-arm, multi-stage CATALYST Trial, is being led by the University of Birmingham in partnership with University Hospitals Birmingham and the Birmingham NIHR Biomedical Research … Read more
First patient recruited for key drug treatment trial
A clinical trial to test whether Azithromycin, a commonly used antibiotic, can treat the symptoms of COVID-19 in outpatients has recruited its first patient. The ATOMIC2 trial, which is being led from Oxford, will enrol 800 people who are being assessed at hospital with COVID-19 but felt well enough to be cared for at home. … Read more
Drug trial could lead to enhanced respiratory care for COVID-19 patients
Researchers at the University of Oxford are working with clinical collaborators from NHS hospitals, including Oxford University Hospitals, to test a drug that could raise oxygen levels in the blood in COVID-19 patients in order to improve their chances of recovery. Raising oxygen levels is important in COVID-19, because many patients with the disease die … Read more
Oxford COVID-19 vaccine to begin phase II/III human trials
University of Oxford researchers have begun recruiting for the next phase in human trials of a COVID-19 vaccine in human volunteers. The phase I trial in healthy adult volunteers began in April. More than 1,000 immunisations have been completed and follow-up is currently ongoing. The next study will enrol up to 10,260 adults and children … Read more
BRC theme lead to study ‘remote-by-default’ care in COVID-19 pandemic
A senior Oxford BRC investigator has received major government funding for a new study to support general practitioners to deliver effective remote care to their patients during the COVID-19 pandemic. Professor Trisha Greenhalgh (pictured right), of the University of Oxford’s Nuffield Department of Primary Care Health Sciences, was awarded £750,000 from the Economic and Social … Read more
Managing clinical trials in a pandemic: interview with Prof Duncan Richards
Professor Duncan Richards, who is Director of the Oxford Clinical Trials Research Unit (OCTRU) as well as the NIHR Oxford Biomedical Research Centre’s Musculoskeletal Co-theme Lead, is at the forefront of Oxford’s strategy on clinical trials for COVID-19. In this interview with the Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDORMS), he discusses how … Read more
Oxford COVID-19 vaccine begins human trial stage
University of Oxford researchers have begun testing a COVID-19 vaccine in human volunteers in Oxford. Around 1,110 people will take part in the trial, half receiving the vaccine and the other half (the control group) receiving a widely available meningitis vaccine. Of the first two volunteers to take part, one likewise received the vaccine and … Read more
Large-scale COVID-19 infection and antibody test study launched
Some 20,000 households across England are being contacted to take part in the first wave of a major new government study to track the COVID-19 coronavirus in the general population. The study will help improve understanding around the current rate of infection and how many people are likely to have developed antibodies to the virus. … Read more
BRC funds three further COVID-19 studies
Three more studies are being funded by the NIHR Oxford Biomedical Research Centre (BRC) to look at the way the body interacts with COVID19; these include assessing the safety of a new vaccine; the role that antibodies might play in plasma therapy; and blood biomarkers that determine adverse reactions in those that have been infected. … Read more
Common antibody test can be adapted for COVID-19, study finds
Research led from Oxford has found that an immunological assay commonly used to measure antibodies, antigens and proteins in biological samples can be specifically adapted to detect and quantifying COVID-19 antibodies. The investigations by the National COVID Testing Scientific Advisory Panel were co-ordinated by Prof Derrick Crook at the University of Oxford. The trial involved researchers at … Read more
Oxford-led research describes the safety profile and potential harms of hydroxychloroquine and azithromycin
Over 300 researchers from the Observational Health Data Sciences and Informatics (OHDSI) international community studied data from almost 1 million patients who have previously taken hydroxychloroquine. They declared hydroxychloroquine safe for short-term use, but urge caution in using it in combination with azithromycin. Led by Prof Dani Prieto-Alhambra, Professor of Pharmaco- and Device Epidemiology at the … Read more
BRC funds new COVID-19 research projects
The NIHR Oxford Biomedical Research Centre (BRC) has allocated funding to three COVID-19 research projects in an attempt to improve treatment, understand how the virus interacts with chronic diseases, and the longer-term effects of infection on organs. The funding, originally earmarked for BRC cross-theme cluster projects, has been diverted to research projects in the BRC’s … Read more
New wearable technology used to monitor COVID-19 patients
Wearable technology that monitors patients’ vital signs is being used with COVID-19 patients on the isolation ward at the John Radcliffe Hospital. The technology has been developed by biomedical engineers and medical researchers supported by the NIHR Oxford Biomedical Research Centre (BRC). The Oxford BRC’s Technology and Digital Health theme, led by Prof Peter Watkinson … Read more
GP practices urged to join COVID-19 research
Oxford researchers have launched a study to track the spread of COVID-19 in the population and develop a deeper understanding of the virus in general practice. The University of Oxford’s Nuffield Department of Primary Care Health Sciences (NDPCHS) and the Royal College of General Practitioners (RCGP) have joined forces with clinical system supplier EMIS Health … Read more
Oxford COVID-19 vaccine programme opens for clinical trial recruitment
University of Oxford researchers, working in an unprecedented vaccine development effort to prevent COVID-19, have started screening healthy volunteers ahead of a vaccine trial. The NIHR Oxford Biomedical Research Centre (BRC) provided essential funding to get the trial up and running. The team will enrol healthy volunteers aged between 18 and 55, who, if they … Read more
Article addresses remote assessment of COVID-19 in primary care
An article by a leading Oxford researcher has outlined the guiding principles on how general practitioners should conduct remote consultations with patients who are suspected of having COVID-19. The article, published in the BMJ, is by Prof Trish Greenhalgh (pictured), the Oxford BRC Theme Lead for Partnerships for Health, Wealth and Innovation, and a Professor … Read more
Oxford researchers to play key role in fight-back against COVID-19
Researchers supported by the NIHR Oxford Biomedical Research Centre will play a crucial role in tackling the current COVID-19 pandemic, ranging from the development of a new vaccine to developing the most effective drug treatments for people who have contracted the virus. A team from the Oxford Vaccine Group and the University of Oxford’s Jenner … Read more
Oxford BRC statement on activities during the current COVID-19 situation
Many of the researchers we support are also clinicians, providing direct care to patients and the public, alongside their academic work. Given the scale of the national and global challenge of COVID-19 (coronavirus), BRC-funded clinical and research professionals who are working on topics other than COVID-19, or those with relevant skills, are being asked to … Read more
- « Previous Page
- 1
- …
- 4
- 5
- 6